Activation of ALDH1A1 in MDA-MB-468 breast cancer cells that over-express CYP2J2 protects against paclitaxel-dependent cell death mediated by reactive oxygen species.
Biochem Pharmacol
; 143: 79-89, 2017 11 01.
Article
in En
| MEDLINE
| ID: mdl-28756208
Key words
1,1,3,3-Tetramethoxypropane (PubChem CID: 66019); 14,15-EET; 2-Thiobarbituric acid (PubChem CID: 2723628); 2',7'-Dichlorofluorescein diacetate (PubChem CID: 101615877); 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (PubChem CID: 64965); 4-Hydroxynonenal (PubChem CID: 5283344); Aldehyde dehydrogenase 1A1; Breast cancer drug resistance; Cell survival; Clotrimazole (PubChem CID: 2812); Cytochrome P450 2J2; Dimethylsulfoxide (PubChem CID: 679); Doxorubicin (PubChem CID: 31703); Malondialdehyde (PubChem CID: 10964); Paclitaxel (PubChem CID: 36314); Reactive oxygen species; Sorafenib (PubChem CID: 216239).; Staurosporine (PubChem CID: 44259)
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Paclitaxel
/
Reactive Oxygen Species
/
Apoptosis
/
Cytochrome P-450 Enzyme System
/
Aldehyde Dehydrogenase
/
Antineoplastic Agents, Phytogenic
Limits:
Female
/
Humans
Language:
En
Journal:
Biochem Pharmacol
Year:
2017
Document type:
Article
Affiliation country:
Australia
Country of publication:
Reino Unido